{
    "2021-07-02": [
        [
            {
                "time": "2021-07-02",
                "original_text": "恒瑞医药入选福布斯中国最佳雇主榜单 可持续发展能力获认可",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "福布斯",
                        "可持续发展"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-07-02",
                "original_text": "超86亿外资今日撤离A股，白酒、医药、银行股集体遭抛售",
                "features": {
                    "keywords": [
                        "外资撤离",
                        "A股",
                        "医药",
                        "白酒",
                        "银行"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "白酒",
                        "银行"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-07-02",
                "original_text": "谊众药业IPO押注紫杉醇：红海里翻波浪",
                "features": {
                    "keywords": [
                        "谊众药业",
                        "IPO",
                        "紫杉醇"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-07-02",
                "original_text": "药明康德领衔，这个医药细分会成为十年十倍的机会么？",
                "features": {
                    "keywords": [
                        "药明康德",
                        "医药细分",
                        "十年十倍"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-07-02",
                "original_text": "“医药一哥”也入局，眼科市场到底有多火？",
                "features": {
                    "keywords": [
                        "医药一哥",
                        "眼科市场"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-07-02",
                "original_text": "创新药史上最大谜团：5年烧掉231亿后，百济神州能留下什么？",
                "features": {
                    "keywords": [
                        "创新药",
                        "百济神州",
                        "烧钱"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-07-02",
                "original_text": "Wind医药：每日行业动态（2021-07-02）",
                "features": {
                    "keywords": [
                        "Wind医药",
                        "行业动态"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-07-01",
                "original_text": "A股融资融券日报：两融余额减少101.12亿元（7月1日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-07-02",
                "original_text": "恒瑞医药SHR1459获批临床；药明康德与通化东宝签署2亿元项目技术转让协议",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "SHR1459",
                        "药明康德",
                        "通化东宝",
                        "技术转让"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}